Scientific paper - Original scientific paper
Treatment with Cladribine Tablets Beyond Year 4: A Position Statement by Southeast European Multiple Sclerosis Centers
Neurology and Therapy, 12 (2022), 1; 25-37. https://doi.org/10.1007/s40120-022-00422-z

Habek, Mario; Drulović, Jelena; Brecl Jakob, Gregor; Barbov, Ivan; Radulovic, Ljiljana; Rajda, Cecilia; Rejdak, Konrad; Turčáni, Peter

Cite this document

Habek, M., Drulović, J., Brecl Jakob, G., Barbov, I., Radulovic, Lj., Rajda, C. ... Turčáni, P. (2022). Treatment with Cladribine Tablets Beyond Year 4: A Position Statement by Southeast European Multiple Sclerosis Centers. Neurology and Therapy, 12. (1), 25-37. doi: 10.1007/s40120-022-00422-z

Habek, Mario, et al. "Treatment with Cladribine Tablets Beyond Year 4: A Position Statement by Southeast European Multiple Sclerosis Centers." Neurology and Therapy, vol. 12, no. 1, 2022, pp. 25-37. https://doi.org/10.1007/s40120-022-00422-z

Habek, Mario, Jelena Drulović, Gregor Brecl Jakob, Ivan Barbov, Ljiljana Radulovic, Cecilia Rajda, Konrad Rejdak and Peter Turčáni. "Treatment with Cladribine Tablets Beyond Year 4: A Position Statement by Southeast European Multiple Sclerosis Centers." Neurology and Therapy 12, no. 1 (2022): 25-37. https://doi.org/10.1007/s40120-022-00422-z

Habek, M., et al. (2022) 'Treatment with Cladribine Tablets Beyond Year 4: A Position Statement by Southeast European Multiple Sclerosis Centers', Neurology and Therapy, 12(1), pp. 25-37. doi: 10.1007/s40120-022-00422-z

Habek M, Drulović J, Brecl Jakob G, Barbov I, Radulovic Lj, Rajda C, and sur.. Treatment with Cladribine Tablets Beyond Year 4: A Position Statement by Southeast European Multiple Sclerosis Centers. Neurology and Therapy [Internet]. 2022 November 17 [cited 2024 July 12];12(1):25-37. doi: 10.1007/s40120-022-00422-z

M. Habek, et al., "Treatment with Cladribine Tablets Beyond Year 4: A Position Statement by Southeast European Multiple Sclerosis Centers", Neurology and Therapy, vol. 12, no. 1, pp. 25-37, November 2022. [Online]. Available at: https://urn.nsk.hr/urn:nbn:hr:105:261927. [Accessed: 12 July 2024]

Please login to the repository to save this object to your list.